FIREFLY NEUROSCIENCE INC
AIFFNASDAQTrading Snapshot
- Day Range
- $1.00 – $1.07
- 52-Week Range
- $0.62 – $3.15
- Volume (shares)
- 90,040
- Avg Volume (shares)
- —
- Shares Outstanding
- 15.7M
- Next Earnings
- —
Fundamentals Snapshot
- Annual Revenue
- $1M
- Last Q Revenue
- $514,000
- P/E Ratio
- —
- P/S Ratio
- 8.7x
- EPS (TTM)
- $-0.60
- Dividend Yield
- —
- Dilution (1yr)
- +61.3%
FIREFLY NEUROSCIENCE INC
AIFF
StockOtter · stockotter.spaceAbout FIREFLY NEUROSCIENCE INC
Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions. The company's primary goal is to enhance patient outcomes for individuals affected by mental illnesses and neurological disorders. Its flagship product, Brain Network Analytics, is a sophisticated software platform engineered to aid in the diagnosis and treatment of a diverse range of cognitive and psychiatric conditions. These conditions encompass, but are not limited to, depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. Firefly Neuroscience, Inc. caters to both pharmaceutical companies and medical practitioners.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Latest News & Updates
Firefly Neuroscience (NASDAQ: AIFF) Strengthens Non-Invasive Brain-Computer Interface Growth Strategy with Commercially Available Versus Platform
– Firefly's AI foundation model, being built on more than 200,000 standardized EEG/ERP brain scans, bolsters its long-term BCI growth opportunity –
Definitive Healthcare (NASDAQ:DH) versus Firefly Neuroscience (NASDAQ:AIFF) Financial Comparison
Definitive Healthcare (NASDAQ: DH - Get Free Report) and Firefly Neuroscience (NASDAQ: AIFF - Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will compare the two business
Firefly Neuroscience and Neurosigma Partner To Expand Non-Drug Pediatric ADHD Care
Firefly Neuroscience Inc. (NASDAQ:AIFF), an artificial intelligence company advancing precision neuroscience, partnered with NeuroSigma, Inc., a bioelectronic medical device firm, to expand clinician awareness and access
Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD
– Partnership will introduce NeuroSigma's second-generation Monarch eTNS ® System to Firefly's nationwide network of Evoke™ clinicians –
Firefly Neuroscience's Evoke™ Platform Selected to Bring Objective Brain-Function Insights to Radial's AI-Native Operating System for Brain Medicine
– This integration of Firefly's FDA 510(k)-cleared, AI-powered EEG/ERP technology follows Radial's August 2026 acquisition of the management services organization supporting Mindful Health Solutions, forming the country
Firefly Neuroscience (NASDAQ:AIFF) vs. Pro Medicus (OTCMKTS:PMCUF) Head-To-Head Analysis
Pro Medicus (OTCMKTS:PMCUF - Get Free Report) and Firefly Neuroscience (NASDAQ: AIFF - Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the s